Current screening guidelines could miss prostate cancer in transgender women receiving estrogen

FHS
June 26, 2024
6:38 pm

Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone therapy.

New FDA rule for pharma advertisements requires side effects to be explained clearly

Ever notice how the narrator of a drug advertisement on TV can breeze through the side effects in a tone that’s easy to tune out?

November 21, 2023

Researchers identify specific genes, brain regions, and cognitive features associated with depression

In studies that examine the depressed brain, researchers were able to identify specific genes, molecules, brain regions, and cognitive features that are associated with the

November 13, 2023

The business of CRISPR’d medicine: Not great

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m really

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.